BOOTHBAY FUND MANAGEMENT, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 53 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$95,000
+6.7%
76,351
+66.5%
0.00%0.0%
Q4 2021$89,000
-44.0%
45,864
-20.8%
0.00%
-50.0%
Q3 2021$159,000
-60.3%
57,916
-54.5%
0.00%
-69.2%
Q2 2021$401,000
-37.4%
127,418
-57.6%
0.01%
-45.8%
Q1 2021$641,000
-29.3%
300,717
-35.7%
0.02%
-29.4%
Q4 2020$907,000467,4360.03%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Henrickson Nauta Wealth Advisors, Inc. 200,000$24,9400.02%
GSA CAPITAL PARTNERS LLP 1,275,215$1590.02%
TKG Advisors, LLC 134,860$16,8170.01%
JOHNSON & JOHNSON 190,494$23,7550.01%
GPS Wealth Strategies Group, LLC 253,205$31,5750.01%
Performa Ltd (US), LLC 90,000$11,2230.01%
Jackson Wealth Management, LLC 23,850$2,9740.00%
Garden State Investment Advisory Services LLC 30,000$3,7410.00%
MAI Capital Management 584,925$72,9400.00%
Twin Lakes Capital Management, LLC 12,500$1,5590.00%
View complete list of VISTAGEN THERAPEUTICS INC shareholders